Web18 hours ago · In the last 3 months, 11 analysts have offered 12-month price targets for PTC. The company has an average price target of $153.91 with a high of $170.00 and a … WebSOUTH PLAINFIELD, N.J. , March 28, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on March 22, 2024, the company approved non-statutory stock options to purchase an aggregate of 58,465 shares of its common stock and 29,710 restricted stock units ("RSUs"), each representing the right to receive one share of …

PTC Therapeutics - Stock Price History PTCT MacroTrends

WebMar 17, 2024 · The latest price target for . PTC Therapeutics (NASDAQ: PTCT) was reported by SVB Leerink on March 17, 2024.The analyst firm set a price target for $48.00 expecting … WebMar 24, 2024 · Why PTC Therapeutics, Inc.’s (PTCT) Stock Is Down 4.35% As of Wednesday, March 22, PTC Therapeutics, Inc.’s PTCT share price has dipped by 4.35%, which has investors questioning if this is right time to buy. Sean Murphy. Price Why PTC Therapeutics, Inc.’s (PTCT) Stock Is Down 4.67% schedule a windows service

PTC Therapeutics - Stock Split History PTCT MacroTrends

WebMar 30, 2024 · PTC Therapeutics, Inc. is a science-driven global biopharmaceutical company. The Company is focused on the discovery, development and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. The Company's portfolio pipeline includes several commercial products and product … WebMar 22, 2024 · PTC Therapeutics, Inc. Stock Price History. PTC Therapeutics, Inc.’s price is currently up 6.14% so far this month. During the month of March, PTC Therapeutics, Inc.’s stock price has reached a high of $49.26 and a low of $42.69. Over the last year, PTC Therapeutics, Inc. has hit prices as high as $55.58 and as low as $25.01. Year to date ... WebWall Street Stock Market & Finance report, prediction for the future: You'll find the PTC Therapeutics share forecasts, stock quote and buy / sell signals below. According to present data PTC Therapeutics's PTCT shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists). russian fighter downed